2015 European guideline on the management of <I>Chlamydia trachomatis</I> infections*

E. Lanjouw; S. Ouburg; H.J. de Vries; A. Stary; K. Radcliffe; M. Unemo

doi:10.5114/dr.2017.68817

eISSN: 2084-9893
ISSN: 0033-2526

Przegląd Dermatologiczny/Dermatology Review

Current issue Archive Dermatology Review

1/2017

Send email

Copy url:

abstract:

Special paper

2015 European guideline on the management of Chlamydia trachomatis infections*

E. Lanjouw

,

S. Ouburg

,

H.J. de Vries

,

A. Stary

,

K. Radcliffe

,

M. Unemo

Przegl Dermatol 2017, 104, e1–e17

DOI: https://doi.org/10.5114/dr.2017.68817

Online publish date: 2017/06/30

View full text Get citation

PlumX metrics:

Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public health concerns globally. The 2015 European C. trachomatis guideline provides up-to-date guidance regarding broader indications for testing and treatment of C. trachomatis infections; clearer recommendation of using exclusively validated NAATs for diagnosis; advice on (repeated) C. trachomatis testing; recommendation of increased testing to reduce the incidence of pelvic inflammatory disease and prevent exposure to infection; and recommendations to identify, verify and report C. trachomatis variants. Improvement of access to testing, test performance, diagnostics, antimicrobial treatment and follow-up of C. trachomatis patients are crucial to control its spread. For detailed background, evidence base and discussions, see the background review for the present 2015 European guideline on the management of Chlamydia trachomatis infections (Lanjouw E, et al. Int J STD AIDS 2015).

keywords:

2015 European guideline on the management of Chlamydia trachomatis infections*

E. Lanjouw , S. Ouburg , H.J. de Vries , A. Stary , K. Radcliffe , M. Unemo

Chlamydia trachomatis, Europe, diagnosis, treatment, antibiotic

E. Lanjouw

,

S. Ouburg

,

H.J. de Vries

,

A. Stary

,

K. Radcliffe

,

M. Unemo